MedTrace Logo

Fertility Restoration Using Autologous Mesenchymal Stem Cells

NCT04432467 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-12-10

No results posted yet for this study

Summary

Treatment of the patients with scarring and adhesions in the uterus resulting from caesarean section or chronic inflammation in the mucosa of the uterus and fallopian tubes and preventing the occurrence of these effects in the future

Conditions

  • Chronic Endometritis
  • Uterus; Scar
  • Uterine Synechiae
  • Fallopian Tube Obstruction

Interventions

BIOLOGICAL

Autologous mesenchymal stem cells

Autologous adipose tissue-derived mesenchymal stem cells

OTHER

standard treatment

standard treatment according to clinical protocols

Sponsors & Collaborators

  • Belarusian Medical Academy of Post-Graduate Education

    collaborator OTHER

  • Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

    lead OTHER_GOV

Principal Investigators

  • Igor D Volotovski, Dr · Head of the Lab of Institute of Biophysics and Cell Engineering

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • Belarus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04432467 on ClinicalTrials.gov